Roth Capital affirms its Focus Pick rating and $15 target price on TG Therapeutics, Inc. (Nasdaq: TGTX) ahead of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE